Radiopharm Theranostics (ASX: RAD, NASDAQ: RADX) announced that its Data Safety and Monitoring Committee (DSMC) has recommended advancing its 177Lu-RAD202 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA